Immunic, Inc. Announces 1-for-10 Reverse Stock Split
Immunic announced a 1-for-10 reverse stock split effective April 27, 2026, reducing outstanding shares from approximately 136 million to 13.6 million. The board approved the specific 1-for-10 ratio within the range approved by stockholders; the action is primarily intended to meet contractual obligations under a securities purchase agreement from February 2026.
Key figures
- Split ratio
- 1-for-10
- Shares pre split
- approximately 136 million
- Shares post split
- approximately 13.6 million
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.